Status:

COMPLETED

Promoting Early Diagnosis of Congenital Hearing Loss With Patient Navigators

Lead Sponsor:

Matthew Bush, MD

Collaborating Sponsors:

National Institute on Deafness and Other Communication Disorders (NIDCD)

National Institutes of Health (NIH)

Conditions:

Congenital Hearing Loss

Eligibility:

All Genders

Phase:

NA

Brief Summary

Hearing loss is the most common sensory congenital disorder and this condition is diagnosable and treatable. Children that are born with hearing loss have to undergo several hearing tests to diagnose ...

Detailed Description

Parents of children who fail infant hearing screening at birth at the University of Kentucky or other hospitals in the area that are receiving follow up diagnostic testing at UK Audiology or the Commi...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (Arm 1):
  • Parents of children who are born at University of Kentucky Medical Center in the postpartum ward whose children are born after 34 weeks gestation and fail hearing screening in one or both ears
  • Parents whose children are receiving follow up testing (due to referral after mandatory newborn hearing screening) at UK Audiology or the Commission for Children with Special Health Care Needs
  • Parents who are willing to be contacted by study coordinators and/or navigator to monitor progress and testing outcomes
  • Parents who are able to speak English or Spanish as the patient navigator will be speaking one of these languages and this will be the primary means of communication over the phone.
  • Exclusion Criteria (Arm 1):
  • Parents of newborns who are hospitalized past 30 days after birth or who are born prior to 34 weeks gestation (as this may inherently delay diagnostic work-up)
  • Children and parents live outside Kentucky or who will be moving out of Kentucky within the first year of life (they will not be able to be followed closely at our institution)
  • Parents of wards of the state and cases of adoption will be excluded
  • Inclusion Criteria (Arm 2):
  • Children who are 6 months old or less and have been diagnosed with hearing loss in one or both ears through two separate ABR tests.
  • Parents who are willing to be contacted by study coordinators and/or navigator to monitor progress and testing outcomes
  • Parents who are able to speak English or Spanish as the patient navigator will be speaking one of these languages and this will be the primary means of communication over the phone.
  • Exclusion Criteria (Arm 2):
  • Parents of newborns who are hospitalized past 30 days after birth or who are born prior to 34 weeks gestation (as this may inherently delay diagnostic work-up)
  • Children and parents live outside Kentucky or who will be moving out of Kentucky within the first year of life (they will not be able to be followed closely at our institution)
  • Parents of wards of the state and cases of adoption will be excluded

Exclusion

    Key Trial Info

    Start Date :

    January 1 2014

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2020

    Estimated Enrollment :

    106 Patients enrolled

    Trial Details

    Trial ID

    NCT01917747

    Start Date

    January 1 2014

    End Date

    January 1 2020

    Last Update

    March 31 2020

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    University of Kentucky

    Lexington, Kentucky, United States, 40536

    2

    Commission for Children with Special Health Care Needs

    Louisville, Kentucky, United States, 40222